Therapeutic Asset Ratings

157 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Abemaciclib Pancreatic Ductal Adenocarcinoma	University Health Network, Toronto	P2	CCC (51)
Ceritinib Cancer	University Health Network, Toronto	P2	CCC (51)
COLCHICINUM Cancer	University Health Network, Toronto	P2	CCC (51)
Dpx-Survivac Cancer	University Health Network, Toronto	P2	CCC (51)
Marijuana Depression	University Health Network, Toronto	P2	CCC (51)
Pyrotinib Large B-cell Lymphoma	University Health Network, Toronto	P2	CCC (51)
rc48-adc Large B-cell Lymphoma	University Health Network, Toronto	P2	CCC (51)
Selinexor Cancer	University Health Network, Toronto	P2	CCC (51)
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2-(((4-(((3-((2R,5S,8S,14R)-5-(3-((AMINOIMINOMETHYL)AMINO)PROPYL)-14-((4-HYDROXYPHENYL)METHYL)-1-METHYL-8-(2-NAPHTHALENYLMETHYL)-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOPENTADEC-2-YL)PROPYL)AMINO)CARBONYL)PHENYL)METHYL)AMINO)-2-OXOETHYL)- Plasma Cell Myeloma	University Health Network, Toronto	P2	CCC (50)
Neratinib Cancer	University Health Network, Toronto	P2	CCC (50)
HUMAN FAECAL MATTER Lymphoma	University Health Network, Toronto	P2	CCC (48)
Atezolizumab Disease Related To Solid Organ Transplantation	University Health Network, Toronto	P1/2	CCC (48)
Samuraciclib Pancreatic Adenosquamous Carcinoma	University Health Network, Toronto	P1/2	CCC (48)
Samuraciclib Mucinous Adenocarcinoma	University Health Network, Toronto	P1/2	CCC (48)
Samuraciclib Malignant Pancreatic Neoplasm	University Health Network, Toronto	P1/2	CCC (48)
Yttrium-90 Disease Related To Solid Organ Transplantation	University Health Network, Toronto	P1/2	CCC (48)
Atezolizumab Macrovascular Invasion	University Health Network, Toronto	P1/2	CC (47)
Humulin R Anhedonia	University Health Network, Toronto	P1/2	CC (47)
Yttrium-90 Macrovascular Invasion	University Health Network, Toronto	P1/2	CC (47)
Alpha Tocopherol Non-Small Cell Lung Carcinoma	University Health Network, Toronto	P2	CC (46)
Pentoxifylline Non-Small Cell Lung Carcinoma	University Health Network, Toronto	P2	CC (46)
Samuraciclib Pancreatic Adenocarcinoma	University Health Network, Toronto	P1/2	CC (45)
Cyclophosphamide NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients	University Health Network, Toronto	P1	CC (43)
Fludarabine NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients	University Health Network, Toronto	P1	CC (43)
Liposomal Curcumin Plasma Cell Myeloma	University Health Network, Toronto	P1	CC (43)

Showing 101 to 125 of 157 assets

PreviousPage 5 of 7Next